The prognostic value of immunohistochemistry biomarkers such as estrogen receptors (52) in GH&PRL-PAs, also requires clarification and the special case of multilineage tumors may provide relevant pathophysiological clues to the understanding of mixed tumors (53). This evidence concerns the gene ESR1 and gonorrhea.